| | | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2026 ( Subtotal = $16,134,023 ) (Continued on the next page) |
| | 2026 | 2026 | THE HENRY M. JACKSON FOUNDATION FOR THE ADVANCEMENT OF MILITARY MEDICINE, INC. | 6720A ROCKLEDGE DR | BETHESDA | MD | 20817-1891 | MONTGOMERY | USA | UM1AI108568 | The Military HIV Research Program (MHRP) Clinical Trial Unit | 008 | 13 | NIH | 2/23/2026 | -$37,500 |
| | 2026 | 2026 | THE HENRY M. JACKSON FOUNDATION FOR THE ADVANCEMENT OF MILITARY MEDICINE, INC. | 6720A ROCKLEDGE DR | BETHESDA | MD | 20817-1891 | MONTGOMERY | USA | R01CA255232 | Isoform-specific signaling as a determinant of RAS-driven oncogenesis | 000 | 5 | NIH | 1/14/2026 | $313,951 |
| | 2026 | 2026 | THE HENRY M. JACKSON FOUNDATION FOR THE ADVANCEMENT OF MILITARY MEDICINE, INC. | 6720A ROCKLEDGE DR | BETHESDA | MD | 20817-1891 | MONTGOMERY | USA | R01AI177698 | Maturation of human humoral immunity through repeat malaria challenges | 000 | 4 | NIH | 5/22/2026 | $760,764 |
| | 2026 | 2026 | THE HENRY M. JACKSON FOUNDATION FOR THE ADVANCEMENT OF MILITARY MEDICINE, INC. | 6720A ROCKLEDGE DR | BETHESDA | MD | 20817-1891 | MONTGOMERY | USA | R01AI168295 | Mechanistic elucidation of pathogenic CBM complex mutations associated with atopic disease | 000 | 4 | NIH | 6/30/2026 | $676,572 |
| | 2026 | 2026 | THE HENRY M. JACKSON FOUNDATION FOR THE ADVANCEMENT OF MILITARY MEDICINE, INC. | 6720A ROCKLEDGE DR | BETHESDA | MD | 20817-1891 | MONTGOMERY | USA | R01AI174908 | A new strategy to eliminate HIV-1-infected cells by unlocking the Env trimer | 000 | 4 | NIH | 6/26/2026 | $681,195 |
| | 2026 | 2026 | THE HENRY M. JACKSON FOUNDATION FOR THE ADVANCEMENT OF MILITARY MEDICINE, INC. | 6720A ROCKLEDGE DR | BETHESDA | MD | 20817-1891 | MONTGOMERY | USA | R01MH130197 | Impact of IL-15 immunotherapy on tissue-specific CD8 T cells to reduce the CNS HIV reservoir seeding and persistence | 000 | 5 | NIH | 8/7/2026 | $397,780 |
| | 2026 | 2026 | THE HENRY M. JACKSON FOUNDATION FOR THE ADVANCEMENT OF MILITARY MEDICINE, INC. | 6720A ROCKLEDGE DR | BETHESDA | MD | 20817-1891 | MONTGOMERY | USA | R01MH130197 | Impact of IL-15 immunotherapy on tissue-specific CD8 T cells to reduce the CNS HIV reservoir seeding and persistence | 000 | 5 | NIH | 8/7/2026 | $571,837 |
| | 2026 | 2026 | THE HENRY M. JACKSON FOUNDATION FOR THE ADVANCEMENT OF MILITARY MEDICINE, INC. | 6720A ROCKLEDGE DR | BETHESDA | MD | 20817-1891 | MONTGOMERY | USA | R21OD038406 | The Mouse Model System for Targeted Trimming of Disease Susceptibility Loci | 000 | 2 | NIH | 5/7/2026 | $149,152 |
| | 2026 | 2026 | THE HENRY M. JACKSON FOUNDATION FOR THE ADVANCEMENT OF MILITARY MEDICINE, INC. | 6720A ROCKLEDGE DR | BETHESDA | MD | 20817-1891 | MONTGOMERY | USA | K01OH012961 | Dynamics of Emotion Regulation, Trauma, and Grief Among Those Impacted by the World Trade Center Attacks | 00 | 2 | CDC | 6/18/2026 | $134,172 |
| | 2026 | 2026 | THE HENRY M. JACKSON FOUNDATION FOR THE ADVANCEMENT OF MILITARY MEDICINE, INC. | 6720A ROCKLEDGE DR | BETHESDA | MD | 20817-1891 | MONTGOMERY | USA | R01AI155983 | Evaluation of Antibody Responses Elicited by Zika Vaccination in Flavivirus-naïve and -experienced Individuals | 001 | 6 | NIH | 6/30/2026 | $0 |
| | 2026 | 2026 | THE HENRY M. JACKSON FOUNDATION FOR THE ADVANCEMENT OF MILITARY MEDICINE, INC. | 6720A ROCKLEDGE DR | BETHESDA | MD | 20817-1891 | MONTGOMERY | USA | R01AI155983 | Evaluation of Antibody Responses Elicited by Zika Vaccination in Flavivirus-naïve and -experienced Individuals | 000 | 6 | NIH | 3/30/2026 | $547,765 |
| | 2026 | 2026 | THE HENRY M. JACKSON FOUNDATION FOR THE ADVANCEMENT OF MILITARY MEDICINE, INC. | 6720A ROCKLEDGE DR | BETHESDA | MD | 20817-1891 | MONTGOMERY | USA | R35GM157233 | Regulation of protein synthesis during cellular stress | 000 | 2 | NIH | 4/21/2026 | $372,880 |
| | 2026 | 2026 | THE HENRY M. JACKSON FOUNDATION FOR THE ADVANCEMENT OF MILITARY MEDICINE, INC. | 6720A ROCKLEDGE DR | BETHESDA | MD | 20817-1891 | MONTGOMERY | USA | R35GM138202 | Cellular organization, division, and differentiation in an ancient, genetically reduced bacterium | 000 | 6 | NIH | 6/3/2026 | $348,726 |
| | 2026 | 2026 | THE HENRY M. JACKSON FOUNDATION FOR THE ADVANCEMENT OF MILITARY MEDICINE, INC. | 6720A ROCKLEDGE DR | BETHESDA | MD | 20817-1891 | MONTGOMERY | USA | R01GM117155 | Regulation of microtubule organizing centers during mammalian gametogenesis | 001 | 12 | NIH | 4/3/2026 | $342,762 |
| | 2026 | 2026 | THE HENRY M. JACKSON FOUNDATION FOR THE ADVANCEMENT OF MILITARY MEDICINE, INC. | 6720A ROCKLEDGE DR | BETHESDA | MD | 20817-1891 | MONTGOMERY | USA | R01HL167048 | COVID-19 airway inflammation is due to Spike inhibition of CFTR signaling | 001 | 4 | NIH | 3/19/2026 | $17,312 |
| | 2026 | 2026 | THE HENRY M. JACKSON FOUNDATION FOR THE ADVANCEMENT OF MILITARY MEDICINE, INC. | 6720A ROCKLEDGE DR | BETHESDA | MD | 20817-1891 | MONTGOMERY | USA | R01HL167048 | COVID-19 airway inflammation is due to Spike inhibition of CFTR signaling | 000 | 4 | NIH | 1/31/2026 | $548,178 |
| | 2026 | 2026 | THE HENRY M. JACKSON FOUNDATION FOR THE ADVANCEMENT OF MILITARY MEDICINE, INC. | 6720A ROCKLEDGE DR | BETHESDA | MD | 20817-1891 | MONTGOMERY | USA | U01AI170033 | Mitigation of Radiation Induced Immune Dysfunction by PrC-210 Treatment | 000 | 5 | NIH | 5/28/2026 | $349,970 |
| | 2026 | 2026 | THE HENRY M. JACKSON FOUNDATION FOR THE ADVANCEMENT OF MILITARY MEDICINE, INC. | 6720A ROCKLEDGE DR | BETHESDA | MD | 20817-1891 | MONTGOMERY | USA | R21AI199351 | Efficacy of a whole inactivated vaccine against EV-D68 infection | 000 | 1 | NIH | 5/26/2026 | $223,728 |
| | 2026 | 2026 | THE HENRY M. JACKSON FOUNDATION FOR THE ADVANCEMENT OF MILITARY MEDICINE, INC. | 6720A ROCKLEDGE DR | BETHESDA | MD | 20817-1891 | MONTGOMERY | USA | T35DC023501 | Short-term clinical and translational research for AuD students | 000 | 1 | NIH | 4/21/2026 | $27,633 |
| | 2026 | 2026 | THE HENRY M. JACKSON FOUNDATION FOR THE ADVANCEMENT OF MILITARY MEDICINE, INC. | 6720A ROCKLEDGE DR | BETHESDA | MD | 20817-1891 | MONTGOMERY | USA | R01NS148504 | Lateral habenula circuit dysfunction in mild traumatic brain injury | 000 | 1 | NIH | 7/7/2026 | $372,880 |
| | 2026 | 2026 | THE HENRY M. JACKSON FOUNDATION FOR THE ADVANCEMENT OF MILITARY MEDICINE, INC. | 6720A ROCKLEDGE DR | BETHESDA | MD | 20817-1891 | MONTGOMERY | USA | R35GM162857 | Metabolic Regulation of Protein Folding Homeostasis | 000 | 1 | NIH | 8/11/2026 | $410,169 |
| | 2026 | 2026 | THE HENRY M. JACKSON FOUNDATION FOR THE ADVANCEMENT OF MILITARY MEDICINE, INC. | 6720A ROCKLEDGE DR | BETHESDA | MD | 20817-1891 | MONTGOMERY | USA | R21DA064084 | High-Risk Medication Prescription Receipt in the Military Health System: Elucidating Patterns and Substance Use Outcomes among Military Service Members | 001 | 1 | NIH | 8/14/2026 | $0 |
| | 2026 | 2026 | THE HENRY M. JACKSON FOUNDATION FOR THE ADVANCEMENT OF MILITARY MEDICINE, INC. | 6720A ROCKLEDGE DR | BETHESDA | MD | 20817-1891 | MONTGOMERY | USA | R21DA064084 | High-Risk Medication Prescription Receipt in the Military Health System: Elucidating Patterns and Substance Use Outcomes among Military Service Members | 000 | 1 | NIH | 8/5/2026 | $207,585 |
| | 2026 | 2026 | THE HENRY M. JACKSON FOUNDATION FOR THE ADVANCEMENT OF MILITARY MEDICINE, INC. | 6720A ROCKLEDGE DR | BETHESDA | MD | 20817-1891 | MONTGOMERY | USA | U01AI187053 | Development of angiogenin as a novel radiation medical countermeasure for acute radiation syndrome | 000 | 2 | NIH | 7/30/2026 | $561,444 |
| | 2026 | 2026 | THE HENRY M. JACKSON FOUNDATION FOR THE ADVANCEMENT OF MILITARY MEDICINE, INC. | 6720A ROCKLEDGE DR | BETHESDA | MD | 20817-1891 | MONTGOMERY | USA | U19AI189178 | Center for Immunological Interventions against Gonorrhea (CIIG) | 000 | 2 | NIH | 7/23/2026 | $4,222,445 |
| | 2026 | 2026 | THE HENRY M. JACKSON FOUNDATION FOR THE ADVANCEMENT OF MILITARY MEDICINE, INC. | 6720A ROCKLEDGE DR | BETHESDA | MD | 20817-1891 | MONTGOMERY | USA | R01NS142032 | Neural Plasticity and Myelin Dynamics after Amputation | 001 | 1 | NIH | 5/4/2026 | $0 |
| | 2026 | 2026 | THE HENRY M. JACKSON FOUNDATION FOR THE ADVANCEMENT OF MILITARY MEDICINE, INC. | 6720A ROCKLEDGE DR | BETHESDA | MD | 20817-1891 | MONTGOMERY | USA | R01NS142032 | Neural Plasticity and Myelin Dynamics after Amputation | 000 | 1 | NIH | 3/5/2026 | $555,265 |
| | 2026 | 2026 | THE HENRY M. JACKSON FOUNDATION FOR THE ADVANCEMENT OF MILITARY MEDICINE, INC. | 6720A ROCKLEDGE DR | BETHESDA | MD | 20817-1891 | MONTGOMERY | USA | R21AI203571 | Structure-based Sieve Analysis to Understand the Impact of Antibody-Mediated Immunity | 000 | 1 | NIH | 8/1/2026 | $317,272 |
| | 2026 | 2026 | THE HENRY M. JACKSON FOUNDATION FOR THE ADVANCEMENT OF MILITARY MEDICINE, INC. | 6720A ROCKLEDGE DR | BETHESDA | MD | 20817-1891 | MONTGOMERY | USA | R01CA252468 | ATR Dependency as a Novel Therapeutic Target in Lethal RB Deficient ProstateCancer | 000 | 8 | NIH | 7/1/2026 | $217,246 |
| | 2026 | 2026 | THE HENRY M. JACKSON FOUNDATION FOR THE ADVANCEMENT OF MILITARY MEDICINE, INC. | 6720A ROCKLEDGE DR | BETHESDA | MD | 20817-1891 | MONTGOMERY | USA | R01LM014784 | Retrospective Magnetic Resonance Image Harmonization for Robust Federated Learning | 000 | 2 | NIH | 5/7/2026 | $326,043 |
| | 2026 | 2026 | THE HENRY M. JACKSON FOUNDATION FOR THE ADVANCEMENT OF MILITARY MEDICINE, INC. | 6720A ROCKLEDGE DR | BETHESDA | MD | 20817-1891 | MONTGOMERY | USA | R01NS145076 | Astrocyte Calcium Signaling in Chronic Pain. | 000 | 2 | NIH | 6/26/2026 | $372,880 |
| | 2026 | 2026 | THE HENRY M. JACKSON FOUNDATION FOR THE ADVANCEMENT OF MILITARY MEDICINE, INC. | 6720A ROCKLEDGE DR | BETHESDA | MD | 20817-1891 | MONTGOMERY | USA | R21AI190739 | Delineating the kinetics of spinal pathology in the EV-D68 infected ferret model | 000 | 2 | NIH | 1/23/2026 | $186,441 |
| | 2026 | 2026 | THE HENRY M. JACKSON FOUNDATION FOR THE ADVANCEMENT OF MILITARY MEDICINE, INC. | 6720A ROCKLEDGE DR | BETHESDA | MD | 20817-1891 | MONTGOMERY | USA | R21DC021516 | Improving Interpretation of Hearing- Related Patient Reported Outcomes for Bilingual Adults | 000 | 3 | NIH | 7/24/2026 | $150,617 |
| | 2026 | 2026 | THE HENRY M. JACKSON FOUNDATION FOR THE ADVANCEMENT OF MILITARY MEDICINE, INC. | 6720A ROCKLEDGE DR | BETHESDA | MD | 20817-1891 | MONTGOMERY | USA | UM1AI108568 | The Military HIV Research Program (MHRP) Clinical Trial Unit | 006 | 13 | NIH | 1/21/2026 | $0 |
| | 2026 | 2026 | THE HENRY M. JACKSON FOUNDATION FOR THE ADVANCEMENT OF MILITARY MEDICINE, INC. | 6720A ROCKLEDGE DR | BETHESDA | MD | 20817-1891 | MONTGOMERY | USA | UM1AI108568 | The Military HIV Research Program (MHRP) Clinical Trial Unit | 005 | 13 | NIH | 1/20/2026 | $0 |
| | 2026 | 2026 | THE HENRY M. JACKSON FOUNDATION FOR THE ADVANCEMENT OF MILITARY MEDICINE, INC. | 6720A ROCKLEDGE DR | BETHESDA | MD | 20817-1891 | MONTGOMERY | USA | UM1AI108568 | The Military HIV Research Program (MHRP) Clinical Trial Unit | 004 | 13 | NIH | 12/30/2025 | $37,500 |
| | 2026 | 2026 | THE HENRY M. JACKSON FOUNDATION FOR THE ADVANCEMENT OF MILITARY MEDICINE, INC. | 6720A ROCKLEDGE DR | BETHESDA | MD | 20817-1891 | MONTGOMERY | USA | UM1AI108568 | The Military HIV Research Program (MHRP) Clinical Trial Unit | 003 | 13 | NIH | 12/29/2025 | $280,319 |
| | 2026 | 2026 | THE HENRY M. JACKSON FOUNDATION FOR THE ADVANCEMENT OF MILITARY MEDICINE, INC. | 6720A ROCKLEDGE DR | BETHESDA | MD | 20817-1891 | MONTGOMERY | USA | UM1AI108568 | The Military HIV Research Program (MHRP) Clinical Trial Unit | 002 | 13 | NIH | 12/22/2025 | $541,241 |
| | 2026 | 2026 | THE HENRY M. JACKSON FOUNDATION FOR THE ADVANCEMENT OF MILITARY MEDICINE, INC. | 6720A ROCKLEDGE DR | BETHESDA | MD | 20817-1891 | MONTGOMERY | USA | UM1AI108568 | The Military HIV Research Program (MHRP) Clinical Trial Unit | 016 | 13 | NIH | 8/20/2026 | $3,239 |
| | 2026 | 2026 | THE HENRY M. JACKSON FOUNDATION FOR THE ADVANCEMENT OF MILITARY MEDICINE, INC. | 6720A ROCKLEDGE DR | BETHESDA | MD | 20817-1891 | MONTGOMERY | USA | UM1AI108568 | The Military HIV Research Program (MHRP) Clinical Trial Unit | 015 | 13 | NIH | 8/18/2026 | $121,225 |
| | 2026 | 2026 | THE HENRY M. JACKSON FOUNDATION FOR THE ADVANCEMENT OF MILITARY MEDICINE, INC. | 6720A ROCKLEDGE DR | BETHESDA | MD | 20817-1891 | MONTGOMERY | USA | UM1AI108568 | The Military HIV Research Program (MHRP) Clinical Trial Unit | 014 | 13 | NIH | 6/11/2026 | $0 |
| | 2026 | 2026 | THE HENRY M. JACKSON FOUNDATION FOR THE ADVANCEMENT OF MILITARY MEDICINE, INC. | 6720A ROCKLEDGE DR | BETHESDA | MD | 20817-1891 | MONTGOMERY | USA | UM1AI108568 | The Military HIV Research Program (MHRP) Clinical Trial Unit | 013 | 13 | NIH | 4/6/2026 | $37,500 |
| | 2026 | 2026 | THE HENRY M. JACKSON FOUNDATION FOR THE ADVANCEMENT OF MILITARY MEDICINE, INC. | 6720A ROCKLEDGE DR | BETHESDA | MD | 20817-1891 | MONTGOMERY | USA | UM1AI108568 | The Military HIV Research Program (MHRP) Clinical Trial Unit | 012 | 13 | NIH | 4/3/2026 | $275,059 |
| | 2026 | 2026 | THE HENRY M. JACKSON FOUNDATION FOR THE ADVANCEMENT OF MILITARY MEDICINE, INC. | 6720A ROCKLEDGE DR | BETHESDA | MD | 20817-1891 | MONTGOMERY | USA | UM1AI108568 | The Military HIV Research Program (MHRP) Clinical Trial Unit | 011 | 13 | NIH | 4/2/2026 | $484,608 |
| | 2026 | 2026 | THE HENRY M. JACKSON FOUNDATION FOR THE ADVANCEMENT OF MILITARY MEDICINE, INC. | 6720A ROCKLEDGE DR | BETHESDA | MD | 20817-1891 | MONTGOMERY | USA | UM1AI108568 | The Military HIV Research Program (MHRP) Clinical Trial Unit | 010 | 13 | NIH | 3/5/2026 | $280,319 |
| | 2026 | 2026 | THE HENRY M. JACKSON FOUNDATION FOR THE ADVANCEMENT OF MILITARY MEDICINE, INC. | 6720A ROCKLEDGE DR | BETHESDA | MD | 20817-1891 | MONTGOMERY | USA | UM1AI108568 | The Military HIV Research Program (MHRP) Clinical Trial Unit | 009 | 13 | NIH | 3/2/2026 | $37,500 |
| | 2026 | 2026 | THE HENRY M. JACKSON FOUNDATION FOR THE ADVANCEMENT OF MILITARY MEDICINE, INC. | 6720A ROCKLEDGE DR | BETHESDA | MD | 20817-1891 | MONTGOMERY | USA | R01CA255232 | Isoform-specific signaling as a determinant of RAS-driven oncogenesis | 001 | 5 | NIH | 4/16/2026 | $34,883 |
| | 2026 | 2026 | THE HENRY M. JACKSON FOUNDATION FOR THE ADVANCEMENT OF MILITARY MEDICINE, INC. | 6720A ROCKLEDGE DR | BETHESDA | MD | 20817-1891 | MONTGOMERY | USA | UM1AI108568 | The Military HIV Research Program (MHRP) Clinical Trial Unit | 007 | 13 | NIH | 2/23/2026 | -$280,319 |
| | 2026 | 2025 | THE HENRY M. JACKSON FOUNDATION FOR THE ADVANCEMENT OF MILITARY MEDICINE, INC. | 6720A ROCKLEDGE DR | BETHESDA | MD | 20817-1891 | MONTGOMERY | USA | R21OD034471 | Identifying the radioprotective potential of radiation-resistant fungi using Drosophila | 000 | 2 | NIH | 6/30/2026 | $0 |
|
